Seems like we should also be able to expect revenue from German HE patients sometime soon too. And: is there anything preventing a german to self-pay, until insurance reimbursement negotiations are completed. Say a rich german patient needs GBM surgery .... couldn't he/she decide to get DCVax-L treatment regardless if/when insurance reimbursement negotiations are completed?